Results 1 to 10 of about 55,801 (184)

Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches [PDF]

open access: yesCancer Immunology, Immunotherapy
On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC).
Amit Sharma   +11 more
doaj   +3 more sources

Dendritic Cell-Cytokine-Induced Killer Cells Co-Loaded with WT1/MUC1/Poly(I:C) Enhance Antitumor Immune Responses In Vitro and In Vivo [PDF]

open access: yesBiomolecules
Dendritic cell-cytokine-induced killer (DC-CIK) therapy faces limitations due to antigenic heterogeneity and suboptimal immune activation. In this study, we developed a multi-antigen-loaded DC-CIK (Ag-DC-CIK) system that co-targets Wilms’ tumor 1 (WT1 ...
Huimin Liu   +6 more
doaj   +2 more sources

Inhibition of human gastric cancer growth by cytokine-induced killer cells plus chemotherapy with or without cadonilimab in a mouse xenograft tumor model [PDF]

open access: yesFrontiers in Immunology
BackgroundCytokine-induced killer (CIK) cell therapy has shown potent antitumor cytotoxicity. To date, no study has evaluated the efficacy and safety of combining CIK cell therapy with chemotherapy, with or without the immune checkpoint inhibitor (ICI ...
Wenwei Yang   +4 more
doaj   +2 more sources

Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma

open access: yesPLoS ONE, 2023
Background Cytokine-induced killer (CIK) cells are heterogeneous lymphocytes from human peripheral blood mononucleated cells (PBMCs) co-cultured with several cytokines.
Chan-Keng Yang   +6 more
doaj   +2 more sources

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer

open access: yesPathology and Oncology Research, 2023
Background: The therapeutic efficacy of cytokine-induced killer (CIK) cells versus dendritic cells (DC) co-cultured with CIK cells (DC-CIK) in treating esophageal cancer (EC) remains unclear due to the absence of a direct comparison of these two regimens.
Jiayang Sun   +3 more
doaj   +1 more source

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation

open access: yesFrontiers in Immunology, 2021
Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus host
Xiaolong Wu   +7 more
doaj   +1 more source

Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing

open access: yesBMC Immunology, 2023
Background Dendritic Cell Cytokine-induced killer cell (DC-CIK) coculture treatment in cancer immunotherapy has been shown to be effective. However, the cost of DC- CIK therapy is prohibitive for many patients, and the lack of standard manufacturing ...
Yi-Yen Lee   +8 more
doaj   +1 more source

Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Background The number of clinical studies evaluating the benefit of cytokine-induced killer cell (CIK) therapy, an adoptive immunotherapy, for colorectal cancer (CRC) is increasing.
Jun Li   +9 more
doaj   +1 more source

Decreasing of heterogeneity in black tiger prawn (Penaeus monodon) and white shrimp (Litopenaeus vannamei) broodstocks and their fry produced in hatchery

open access: yesJurnal Akuakultur Indonesia, 2009
Domestication and genetic improvement of shrimp are required towards production of superior broodstock.  BBPBAP Jepara had performed study on evaluation of genetic diversity of black tiger and white shrimp broodstock and their progenies produced in ...
Bambang Widyo Prastowo   +2 more
doaj   +1 more source

Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma

open access: yesFrontiers in Immunology, 2022
Cytokine-induced killer cells (CIK) in combination with dendritic cells (DCs) have shown favorable outcomes in renal cell carcinoma (RCC), yet some patients exhibit recurrence or no response to this therapy.
Ying Zhang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy